12/9
07:09 am
crbp
Corbus Pharmaceuticals Announces Dosing of First Patient in its First-In-Human Study of CRB-601 to Treat Patients with Advanced Solid Tumors [Yahoo! Finance]
Low
Report
Corbus Pharmaceuticals Announces Dosing of First Patient in its First-In-Human Study of CRB-601 to Treat Patients with Advanced Solid Tumors [Yahoo! Finance]
12/9
07:00 am
crbp
Corbus Pharmaceuticals Announces Dosing of First Patient in its First-In-Human Study of CRB-601 to Treat Patients with Advanced Solid Tumors
Low
Report
Corbus Pharmaceuticals Announces Dosing of First Patient in its First-In-Human Study of CRB-601 to Treat Patients with Advanced Solid Tumors
12/4
12:45 pm
crbp
Why Is Corbus Pharmaceuticals Holdings, Inc. (CRBP) Among the Best Small-Cap Biotech Stocks With Massive Potential According to Hedge Funds? [Yahoo! Finance]
Low
Report
Why Is Corbus Pharmaceuticals Holdings, Inc. (CRBP) Among the Best Small-Cap Biotech Stocks With Massive Potential According to Hedge Funds? [Yahoo! Finance]
12/3
07:18 am
crbp
FDA Grants Fast Track Designation to CRB-701 for the Treatment of Relapsed or Refractory Metastatic Cervical Cancer [Yahoo! Finance]
High
Report
FDA Grants Fast Track Designation to CRB-701 for the Treatment of Relapsed or Refractory Metastatic Cervical Cancer [Yahoo! Finance]
12/3
07:00 am
crbp
FDA Grants Fast Track Designation to CRB-701 for the Treatment of Relapsed or Refractory Metastatic Cervical Cancer
High
Report
FDA Grants Fast Track Designation to CRB-701 for the Treatment of Relapsed or Refractory Metastatic Cervical Cancer
12/2
08:06 am
crbp
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $35.00 price target on the stock.
Low
Report
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $35.00 price target on the stock.
11/26
07:01 am
crbp
Corbus Pharmaceuticals Holdings, Inc. (CRBP): An Oversold Healthcare Stock to Invest In Now [Yahoo! Finance]
Low
Report
Corbus Pharmaceuticals Holdings, Inc. (CRBP): An Oversold Healthcare Stock to Invest In Now [Yahoo! Finance]
11/21
08:00 am
crbp
Corbus Pharmaceuticals to Present at the 7th Annual Evercore HealthCONx Conference
Medium
Report
Corbus Pharmaceuticals to Present at the 7th Annual Evercore HealthCONx Conference
11/12
08:00 am
crbp
Corbus Pharmaceuticals to Present at the Jefferies London Healthcare Conference
Low
Report
Corbus Pharmaceuticals to Present at the Jefferies London Healthcare Conference
11/9
10:11 am
crbp
We're Not Very Worried About Corbus Pharmaceuticals Holdings' (NASDAQ:CRBP) Cash Burn Rate [Yahoo! Finance]
Low
Report
We're Not Very Worried About Corbus Pharmaceuticals Holdings' (NASDAQ:CRBP) Cash Burn Rate [Yahoo! Finance]
11/7
07:00 am
crbp
Corbus Pharmaceuticals Reports 3rd Quarter 2024 Financial Results and Provides a Corporate Update
Low
Report
Corbus Pharmaceuticals Reports 3rd Quarter 2024 Financial Results and Provides a Corporate Update
11/4
10:47 pm
crbp
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $51.00 price target on the stock.
Low
Report
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $51.00 price target on the stock.
11/4
07:00 am
crbp
Corbus Pharmaceuticals Presents New CRB-913 Pre-Clinical Data At Obesity Week 2024
Medium
Report
Corbus Pharmaceuticals Presents New CRB-913 Pre-Clinical Data At Obesity Week 2024
10/29
08:00 am
crbp
Corbus Pharmaceuticals to Present at the Guggenheim Securities Healthcare Innovation Conference
Low
Report
Corbus Pharmaceuticals to Present at the Guggenheim Securities Healthcare Innovation Conference
10/16
08:00 am
crbp
Corbus Announces Enrollment Completion of Dose Escalation Stage of Phase 1 Clinical Trial of Its Next Generation Nectin-4 Targeting ADC (CRB-701)
Low
Report
Corbus Announces Enrollment Completion of Dose Escalation Stage of Phase 1 Clinical Trial of Its Next Generation Nectin-4 Targeting ADC (CRB-701)
9/26
08:00 am
crbp
Corbus Pharmaceuticals to Participate in the BMO Capital Markets’ Oncology Summit
Low
Report
Corbus Pharmaceuticals to Participate in the BMO Capital Markets’ Oncology Summit
9/23
08:17 am
crbp
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $80.00 price target on the stock.
Medium
Report
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $80.00 price target on the stock.